Peiyuan Wang, Yujie Chen, Feng Wang, Mingqiu Chen, Buhong Zheng, Derong Zhang, Qingfeng Zheng, Jiezhong Wang, Junqiang Chen, Huaxin Cai, Junhua Liu, Wenshan Zhang, Changhong Lian, Juhui Chen, Yu Lin, Yuanji Xu, Rongfang Huang, Mengxia Lei, Peng Chen, Hao He, Hui Lin, Xiaofeng Chen, Hang Zhou, Weijie Chen, Wenwei Wei, Fengnian Zhuang, Junpeng Lin, Canhua Huang, Ni Guan, Jin Yan, Shujun Liang, Shuoyan Liu, Jiancheng Li. "Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)." Nature Communications, 2025. doi:10.1038/s41467-025-64660-z